Shanghai Pharmaceutical: the application for non-public offering of a shares was approved by the CSRC
Shanghai Pharmaceutical announced that the issuance Review Committee of China Securities Regulatory Commission (hereinafter referred to as "CSRC") reviewed the application of Shanghai Pharmaceutical Group Co., Ltd. for non-public issuance of a shares in 2021 on March 14, 2022. According to the review results of the meeting, the company's application for non-public offering of a shares was approved.
Briefing May 24, 2022 09:04 AM
· Financials
Xuancheng, Anhui: the upper limit of the unified provident fund loan is 500000 yuan, and the number of talents is increased by 100000 yuan
In-depth
Technology
ePropulsion: Pioneering Electric Marine Propulsion for a Sustainable Future
EqualOcean recently had an insightful conversation with Mr. Tao Shizheng, the visionary founder of ePropulsion (Chinese: 逸动科技), we embarked on a journey to understand the essence of the company's profound impact on the electric marine propulsion industry.
Jan 25, 2024 02:24 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Dec 13, 2021 12:39 PM
· Financials
Change of legal representative of ant fund
Briefing Nov 26, 2021 08:09 PM
· Technology
Hang Seng Electronics: it plans to increase the capital of Yunying network by 630 million yuan, and its shareholding will increase to 98.2835%
See more
Read next
Insight
In-depth
Insight
In-depth